VR-PAT and FNIRS to Identify CNS Biomarkers of Pain
Launched by NATIONWIDE CHILDREN'S HOSPITAL · Mar 4, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how we can better identify and measure pain in children who are experiencing acute pain from burns, especially during dressing changes. Researchers will use a technology called functional near-infrared spectroscopy (fNIRS), which is a non-invasive method that helps measure brain activity related to pain. Additionally, the study will explore how virtual reality (VR) can help relieve pain during these procedures.
To participate in this study, children aged 6 to 17 years who are being treated for a burn injury and need their dressings changed daily for three days may be eligible. It’s important that both the child and their family can communicate in English. Participants can expect to undergo some assessments to measure their pain and may also experience using virtual reality to help manage that pain during their treatment. This study is not yet recruiting participants, but it aims to help improve pain management for young patients dealing with burns.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Being treated for acute burn injury
- • 2. Age 6-17 years, inclusive
- • 3. Admitted to NCH burn unit for treatment
- • 4. Have a dressing that requires daily changes over 3 days
- • 5. Patient and family caregivers can communicate (read and write) using English
- Exclusion Criteria:
- • 1. Any wounds that may interfere with study procedures
- • 2. Vision, hearing, or cognitive/motor impairments preventing valid administration of study measures
- • 3. History of motion sickness, seizure disorder, dizziness, or migraine headaches precipitated by visual auras
- • 4. Minors in foster care, prisoners, or currently pregnant
- • 5. Suspected child abuse
- • 6. Unable to communicate in English
About Nationwide Children's Hospital
Nationwide Children's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and trials. As a prominent sponsor, the hospital leverages its expertise in pediatric medicine to design and conduct rigorous clinical studies aimed at improving treatment outcomes for children. Committed to excellence in research and patient care, Nationwide Children's Hospital collaborates with a network of healthcare professionals and institutions to translate scientific discoveries into effective therapies, ensuring that the latest advancements in pediatric healthcare are accessible to young patients across the nation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Henry Xiang, MD, MPH, PhD, MBA
Principal Investigator
Nationwide Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported